Federal Register / Vol. 87, No. 5 / Friday, January 7, 2022 / Notices 975 

This a new two-year ATSDR 

information collection request (ICR) for 

a collaborative study between the 

Centers for Disease Control and 

Prevention’s National Center for 

Environmental Health (CDC/NCEH) and 

ATSDR. This follow-up study will 

recruit participants who; (1) 

participated in a previous ATSDRfunded study, (2) have existing serumPFAS measurements, and (3) have given 

prior consent for additional contact 

from NCEH/ATSDR. We anticipate that 

the total number of participants enrolled 

in the CDC/ATSDR cohorts will be 

around 3,170 (2,800 adults and 370 

children) individuals. This study will 

attempt to enroll the entire universe of 

eligible participants; therefore, our 

target sample size is 3,170. The cohorts 

have a substantial number of 

participants with high PFAS exposure, 

as well as a sufficient range of serumPFAS concentrations to allow 

examination of associations between the 

outcomes and across a wide range of 

PFAS exposures. 

The objectives are the following: (1) 

To examine the association between 

serum-PFAS collected through the EAs, 

PEATT assessments, and Pease Study 

and the frequency of occurrence of 

selected syndromes (combinations of 

self-reported symptoms), which will be 

used as a proxy for viral infections; and, 

(2) to examine the association between 

serum-PFAS collected through the EAs, 

PEATT assessments, and Pease Study 

and self-reported positive test results 

indicating specific viral infections. 

During the first three months of the 

two-year study period, NCEH/ATSDR 

will invite and consent approximately 

3,170 participants (2,800 adults and 370 

children) to complete a new series of 

surveys to determine whether PFAS 

exposure increases susceptibility to 

viral infections, including, but not 

limited to COVID–19. Data will be 

collected from those who enroll in the 

study through an initial paper-based 

survey and a series of four additional 

surveys over a 12- to 14-month period. 

Follow-up surveys will be offered in 

two modes: Web-based and paper-based. 

It is estimated that 75% of the 

participants will choose the web-based 

mode. Participants will also be given 

symptom diaries to improve recall after 

the initial and between each of the 

follow-up surveys. 

The total time burden requested is 

19,816 hours (or 9,908 hours annually). 

There are no costs to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Adults ...................................... Initial Questionnaire—Adult (paper) ....................................... 700 1 30/60 

Follow up Questionnaire—Adult (paper) ................................ 175 4 30/60 

Follow up Questionnaire—Adult (REDCap) ........................... 525 4 25/60 

Symptom Diary ....................................................................... 700 1 4 

Children (7–17 years) ............. Initial Questionnaire—Child (paper) ....................................... 70 1 30/60 

Follow up Questionnaire—Child (paper) ................................ 18 4 30/60 

Follow up Questionnaire—Child (REDCap) ........................... 52 4 25/60 

Symptom Diary ....................................................................... 70 1 4 

Parents of Children (3–6 

years).

Initial Questionnaire—Child (paper) ....................................... 12 1 30/60 

Follow up Questionnaire—Child (paper) ................................ 6 4 30/60 

Follow up Questionnaire—Child (REDCap) ........................... 18 4 25/60 

Symptom Diary ....................................................................... 23 1 4 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–00101 Filed 1–6–22; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

Kinshasa School of Public Health, 

Democratic Republic of the Congo 

(KSPH, DRC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $700,000, with 

an expected total funding of $3,500,000 

over a five-year period, to the Kinshasa 

School of Public Health, Democratic 

Republic of the Congo (KSPH DRC). The 

award will support the investigation of 

the epidemiological, ecological, and 

anthropological aspects of monkeypox 

and assess clinical intervention 

strategies in the Democratic Republic of 

Congo (DRC). These activities align with 

CDC priorities to promote surveillance 

and global health to prevent the 

international spread of diseases and to 

control them at the source. 

DATES: The period for this award will be 

September 30, 2022, through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Amy Yang, National Center for HIV, 

Viral Hepatitis, STD, and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

MS US8–1, Atlanta, GA 30329–4027, 

Telephone: 404–718–8835, Email: corp_

erpo_8835@cdc.gov. 

SUPPLEMENTARY INFORMATION: This 

single-source award will support the 

investigation of the epidemiological, 

ecological, and anthropological aspects 

of monkeypox and assess clinical 

intervention strategies in the DRC. 

Research activities will focus on 

improvement and evaluation of labbased surveillance systems, 

investigations of animal reservoirs and 

human behaviors at the human-animal 

interface, epidemiologic investigations, 

genome sequencing and phylogenetic 

analysis, risk mitigation, enhancing 

health communication strategies, and 

clinical evaluation of vaccines and 

therapeutic treatments. The research 

should provide the DRC Ministry of 

Health and other key stakeholders with 

evidence-based strategies to develop 


tkelley on DSK125TN23PROD with NOTICE 
976 Federal Register / Vol. 87, No. 5 / Friday, January 7, 2022 / Notices 

monkeypox and other zoonotic disease 

interventions. 

The Kinshasa School of Public Health, 

Democratic Republic of the Congo 

(KSPH, DRC) is in a unique position to 

conduct this work, as it has a distinct 

role in the public health system of DRC 

by being both an institute of the 

University of Kinshasa and previously 

serving as the bone fide agent of the 

Ministry of Health; is the implementing 

partner for an open label trial of 

JYNNEOS smallpox vaccine in the 

healthcare workers of Tshuapa Province 

(2017–present), a study that will 

continue under the new cooperative 

agreement; along with their partners at 

the University of Kinshasa, has 10 years 

of experience in conducting rigorous 

investigations of potential monkeypox 

reservoir species; and has continually 

maintained a field office in Tshuapa 

Province devoted to monkeypox 

surveillance and research since 2011. 

This longstanding commitment to 

working in this area has yielded the 

most thorough longitudinal dataset on 

monkeypox incidence globally since 

smallpox eradication. No other 

indigenous or foreign institution has 

been able to sustain a continual field 

site for this length of time in a 

monkeypox-endemic area of DRC. 

Summary of the Award 

Recipient: The Kinshasa School of 

Public Health, Democratic Republic of 

the Congo (KSPH, DRC). 

Purpose of the Award: The purpose of 

this award is to investigate the 

epidemiological, ecological, and 

anthropological aspects of monkeypox 

and assess clinical intervention 

strategies in the Democratic Republic of 

Congo (DRC). This research may extend 

to other zoonotic and vaccinepreventable diseases that are of 

importance in the DRC and elsewhere. 

Amount of Award: $700,000 in 

Federal Fiscal Year (FYY) 2022 funds, 

and an estimated $700,000 for each 

subsequent 12-month budget period 

over five years, subject to availability of 

funds. 

Authority: This program is authorized 

under Public Health Service Act, 

Sections 301(a) [42 U.S.C. 241(a)] and 

307 [42 U.S.C. 242l]. 

Period of Performance: September 30, 

2022, through September 29, 2027. 

Dated: January 4, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–00078 Filed 1–6–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–0213; Docket No. CDC–2022– 

0004] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled National Vital Statistics Report 

(NVSR) Form. The NVSR Forms collects 

annual statistics on marriage and 

divorce and is used to permit 

uninterrupted tracking of family 

dynamics. 

DATES: Written comments must be 

received on or before March 8, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0004 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to Regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

Regulations.gov. 

Please note: All public comment 

should be submitted through the 

Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. The 

OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Vital Statistics Report 

(NVSR) Forms (OMB Control No. 0920– 

0213, Exp. 10/31/2023)—Revision— 

National Center for Health Statistics 

(NCHS), Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The compilation of national vital 

statistics dates back to the beginning of 

the 20th century and has been 

conducted since 1960 by the Division of 

Vital Statistics of the National Center for 

Health Statistics (NCHS), CDC. The 

collection of data is authorized by 42 

U.S.C. 242k. This submission requests 

to continue use of the Annual Vital 


tkelley on DSK125TN23PROD with NOTICE